DNUT:NASDAQKrispy Kreme, Inc. Analysis
Data as of 2026-06-09 - not real-time
$3.70
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Krispy Kreme’s stock is trading at $3.70, well below its 20‑day, 50‑day and 200‑day moving averages, signaling a bearish technical backdrop. The RSI sits around 60, hinting at neutral‑to‑slightly‑overbought momentum, while the MACD histogram is positive, offering a modest bullish signal. Volatility is elevated at over 50% for the past 30 days and beta exceeds 1.1, indicating the share moves more aggressively than the market. Recent Q1 results showed a 2.2% revenue decline and a non‑GAAP loss of $0.05 per share, missing consensus, yet the stock rallied on the news. Fundamentally, the company posts negative operating and profit margins, a steep debt‑to‑equity ratio above 200%, and a negative ROE, while cash on hand is modest relative to debt. The dividend yield appears attractive at 3.5%, but the payout ratio is high and earnings are negative, raising sustainability concerns. Analyst consensus points to a mean target of $4.35, implying roughly 17% upside from current levels.
Given the juxtaposition of a defensive consumer sector, a cheap price‑to‑sales multiple, and a solid dividend, there is a case for a modest upside play, but the heavy debt load and earnings weakness temper enthusiasm. The short‑term outlook remains cautious, the medium‑term view leans toward a selective buy on valuation and dividend appeal, and the long‑term stance is to monitor debt reduction and earnings recovery before committing fully.
Given the juxtaposition of a defensive consumer sector, a cheap price‑to‑sales multiple, and a solid dividend, there is a case for a modest upside play, but the heavy debt load and earnings weakness temper enthusiasm. The short‑term outlook remains cautious, the medium‑term view leans toward a selective buy on valuation and dividend appeal, and the long‑term stance is to monitor debt reduction and earnings recovery before committing fully.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Recent earnings miss and revenue decline
- Price below key moving averages indicating bearish bias
- MACD bullish divergence offering limited upside
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- Analyst price targets suggest ~17% upside
- Attractive dividend yield relative to peers
- Low price‑to‑sales multiple providing value entry
Long Term
> 3 yearsNeutral
Model confidence: 6/10
Key Factors
- High debt‑to‑equity ratio and negative ROE
- Uncertain earnings sustainability and dividend coverage
- Defensive consumer sector offering resilience over time
Key Metrics & Analysis
Financial Health
Revenue Growth-2.20%
Profit Margin-33.36%
P/E Ratio69.3
ROE-58.15%
ROA-1.16%
Debt/Equity201.77
P/B Ratio1.0
Op. Cash Flow$74.9M
Free Cash Flow$22.4M
Technical Analysis
TrendBearish
RSI60.2
Support$3.10
Resistance$3.80
MA 20$3.36
MA 50$3.50
MA 200$3.62
MACDBullish
VolumeStable
Fear & Greed Index87.64
Valuation
Target Price$4.35
Upside/Downside17.57%
GradeFair
TypeValue
Dividend Yield3.47%
Risk Assessment
Beta1.13
Volatility54.00%
Sector RiskLow
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.